Related Experiment Video
Updated: Nov 7, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation
Carlo Maria Barbagallo1, Angelo Baldassare Cefalù1, Antonina Giammanco1
1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties-University of Palermo, Via del Vespro, 127, 90127 Palermo, Italy.
Insights
Chronic kidney disease (CKD) is linked to cardiovascular disease (CVD) due to lipid and lipoprotein abnormalities. Managing these dyslipidemias may improve outcomes for CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Lipid Metabolism
Background:
- Chronic kidney disease (CKD) is a significant risk factor for cardiovascular disease (CVD).
- Patients with advanced CKD often exhibit dyslipidemia, characterized by lipid and lipoprotein alterations.
- These alterations play a crucial role in the development of CVD in CKD patients.
Purpose of the Study:
- To review lipid and lipoprotein disturbances in CKD.
- To analyze the relationship between these disturbances and CKD progression.
- To discuss the impact of hypolipidemic treatments on CVD in CKD patients.
Main Methods:
- Literature review focusing on lipid metabolism in CKD.
- Analysis of lipoprotein abnormalities and their association with CVD.
- Examination of treatment strategies for dyslipidemia in CKD.
Main Results:
- Hypertriglyceridemia is a primary lipid disorder in CKD, alongside other lipoprotein abnormalities.
- Impaired enzyme pathways and proteins affect lipoprotein metabolism in CKD.
- Renal transplantation can lead to hypercholesterolemia.
Conclusions:
- Lipid and lipoprotein disturbances are integral to CKD pathophysiology and CVD risk.
- Understanding these alterations is key for managing CKD progression and cardiovascular complications.
- Hypolipidemic treatments offer potential strategies to alter the natural history of CVD in CKD patients.
Abstract:
Chronic kidney disease (CKD) is one of the most important risk factors for cardiovascular disease (CVD). Despite the kidney having no direct implications for lipoproteins metabolism, advanced CKD dyslipidemia is usually present in patients with CKD, and the frequent lipid and lipoprotein alterations occurring in these patients play a role of primary importance in the development of CVD. Although hypertriglyceridemia is the main disorder, a number of lipoprotein abnormalities occur in these patients. Different enzymes pathways and proteins involved in lipoprotein metabolism are impaired in CKD. In addition, treatment of uremia may modify the expression of lipoprotein pattern as well as determine acute changes. In renal transplantation recipients, the main lipid alteration is hypercholesterolemia, while hypertriglyceridemia is less pronounced. In this review we have analyzed lipid and lipoprotein disturbances in CKD and also their relationship with progression of renal disease. Hypolipidemic treatments may also change the natural history of CVD in CKD patients and may represent important strategies in the management of CKD patients.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

